Flash Therapeutics
Yokohama, Kanagawa, Japan
About Flash Therapeutics
Flash Therapeutics develops drug candidates to selectively target leukemic stem cells and prevent AML relapse.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Last round: Series Unknown (Jan 2022)
- Website: flashthera.com
Industries & Categories
Manufacturing, Medical
Canonical: https://fsome.com/organization/flash-therapeutics-2605648 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.